Search the Newsreel

Enterprise value to EBIT forward of K Wave Media, Ltd. – BOATS:KWMWW

This article provides financial data for K Wave Media, Ltd. (KWMWW), specifically focusing on its enterprise value to EBIT forward. It presents a value for a particular period, highlighting that this financial metric was "Made by humans." The data is presented within the context …

Liberty Media (FWONA): Wisconsin fund discloses 4.98% Formula One stake

The State of Wisconsin Investment Board has reported a 4.98% stake in Liberty Media Corp Series A Liberty Formula One Common Stock (FWONA), holding 1,195,287 shares. The fund maintains sole voting and dispositive power over these shares, indicating a passive investment just below the …

Trump Media (DJT) interim CEO uses 16,509 shares to cover tax withholding

Trump Media & Technology Group Corp.'s interim CEO, Kevin McGurn, reported a Form 4 transaction where he disposed of 16,509 shares of common stock. This disposition was solely to cover tax withholding payments by the company, not for personal cash proceeds. After the transaction, …

Sumitomo Mitsui Trust Group Inc. Acquires Shares of 534,803 Medical Properties Trust, Inc. $MPT

Hony Media Group Flags Sharply Reduced Loss on Segment Turnaround and Asset Disposal

OrbusNeich (SEHK:6929) Stock Catches Eyes As Margin Softening Meets Profit Growth

Phoenix Media Revamps Board With Director Resignations and New Appointment

Phoenix Media Sets Independent Oversight for Executive Pay and Incentive Policies

Phoenix Media Investment Details Board Line-Up and Governance Committees

AMS secures shareholder support for planned sale to H.B. Fuller

This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Dive Brief: Advanced Medical Solutions Group's shareholders have approved the planned sale of the company to H.B. Fuller for 715 million pounds. …

Beijing Media Reschedules Extraordinary General Meeting and Adjusts Book Closure Dates

Media Chinese International Wins Strong Shareholder Backing at 2026 AGM

Beijing Media Calls EGM to Approve Higher Caps on Beijing Capital Group Marketing Deal

Beijing Tong Ren Tang Chinese Medicine Sets Board Meeting to Approve Interim Results and Consider Dividend

Everest Medicines Sets Out Board Structure and Key Governance Committees

BeOne Medicines Sets Audit Committee Review for Dual-Market Interim Results

Bharatiya Global Infomedia Clears Q1 FY27 Results Amid Compliance Concerns and Board Changes

Diversify Wealth Management LLC Makes New $1.53 Million Investment in Medical Properties Trust, Inc. $MPT

Bodhi Tree Multimedia Q1 Results: Revenue up 72%, EBITDA rises 161%

Zhejiang Taimei Schedules Board Meeting to Approve Interim Results and Mull Dividend

Genertec Universal Medical Subsidiary to Issue Second Tranche of RMB Medium-Term Notes

Journey Medical (FBIO) Q2 2026 Earnings Call: Revenue Rises 23% as Emrosi Accelerates

Journey Medical (FBIO) reported a 23% year-over-year revenue increase to $18.5 million in Q2 2026, primarily driven by strong performance from its rosacea product, Emrosi, which generated $8.1 million in net revenue and saw a 20% sequential rise in prescriptions. The company achieved positive …

National CineMedia, Inc. (NASDAQ:NCMI) Given Average Rating of "Hold" by Brokerages

National CineMedia, Inc. (NASDAQ:NCMI) has received a consensus "Hold" rating from six analysts, with an average 12-month price target of $4.81. The company recently reported quarterly results that missed expectations, with a $0.10 per-share loss and revenue of $58.4 million. An insider sold 12,058 …

Avita Medical Stock Price Forecast. Should You Buy AVH.AX?

Utah Medical Products (NASDAQ:UTMD) Shares Pass Above 200 Day Moving Average - Time to Sell?

Utah Medical Products (NASDAQ:UTMD) shares have risen above their 200-day moving average, reaching $72.37 against an average of $66.51. The company reported quarterly earnings of $0.84 per share on $8.53 million in revenue and declared a $0.31 quarterly dividend, equivalent to a 1.7% annual …

Asset Management One Co. Ltd. Purchases New Position in Medical Properties Trust, Inc. $MPT

Asset Management One Co. Ltd. has acquired a new stake in Medical Properties Trust, Inc. (NYSE:MPT), purchasing 699,754 shares valued at approximately $3.23 million. This new position represents a 0.12% ownership in the company. Medical Properties Trust recently reported quarterly EPS of $0.15 and …

Fischer Medical Ventures Q1 Consolidated Net Profit Declines To ₹3.8 Crore From ₹5 Crore YoY

Profound Medical Corp. Share Price Live Today – NASDAQ:PROF Stock Price, Chart, News, History

Apyx Medical Corporation (APYX) Stock Falls on Q2 2026 Earnings

Banca Mediolanum S.p.A.: prezzo obiettivo e consensus degli analisti| BMED | IT0004776628| MarketScreener Italia

Key facts: MediWound Ltd. (MDWD) Q2 $3.09M rev; EscharEx $4B target

MediWound Ltd. (MDWD) reported Q2 2026 revenue of $3.09–3.10M, with a net loss of $7.39M and shares down 5.4% for the quarter. The company stated that its therapy, EscharEx, is targeting a $4 billion U.S. non-surgical tissue repair market, which it identifies as its …

Penthrox powers Medical Developments International (ASX:MVP) back to positive cash flow as paediatric approvals land

Strata critical medical director Reginald Love disposes of $29,273 in stock

Reginald Love, a director at Strata Critical Medical (NASDAQ:SRTA), sold 5,091 shares of the company's Class A common stock for a total of $29,273 on August 10, 2026. Following this transaction, Love still directly holds 146,481 shares. The company's stock has seen significant gains …

CorMedix Inc (NASDAQ:CRMD) Receives Average Rating of "Moderate Buy" from Brokerages

CorMedix Inc (NASDAQ:CRMD) has received an average "Moderate Buy" rating from brokerages, with six out of eight analysts recommending a buy and two recommending a hold. The company's average 12-month price target is $14.86. This follows a strong second quarter where CorMedix beat revenue …

Nova Eye Medical (ASX:EYE)Turns the Corner on Profit as US Glaucoma Sales Surge

Parabilis Medicines (PBLS) boosts cash above $1.1B after IPO and Regeneron deal

Parabilis Medicines, Inc. reported its Q2 2026 results, showing a significant increase in cash and cash equivalents to over $1.1 billion. This boost follows its June 2026 IPO, which generated $787.9 million in net proceeds, and a $50.0 million upfront payment from its collaboration …